Tocılızumab ELISA (mAb-based)

Enzyme immunoassay for the specific and quantitative determination of free Tocilizumab (Actemra®) in serum and plasma.

The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Tocilizumab. Another POD-labelled specific monoclonal antibody is used as conjugate.

Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.

Assay Format: Double specific mAb-based

Reference: IG-AB108

Barcode: 8682754930233

Legal Status: CE-Mark

Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

Related Documents

Quality Control Certificates

CoA AB108-105 

Required Volume (µL) 10
Incubation Time (min) 130
Sample Serum or Plasma
Package Size 96
Standard Range (ng/mL, 10x) 0-2000
Detection Limit (ng/mL) 5
Spike Recovery (%) >95
Shelf Life (years) 2